Current Enzyme Inhibition

Editor-in-Chief

Claudiu T. Supuran
(83932 citations)
Neurofarba Department
University of Florence
Florence
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 4 Issue: 3, October

Potential Lithium and Fluoride Interactions in Studies of Glycogen Synthase Kinase-3

Volume:4   Issue: 3
Pp: 93-99
Anna Strunecka and Jiri Patocka
DOI: 10.2174/157340808785909394
Published on: 01 March, 2012

Fatty Acid Synthase: A Target for the Reversal of Liver Steatosis

Volume:4   Issue: 3
Pp: 100-108
Zachary P. Evans, Justin D. Ellett and Kenneth D. Chavin
DOI: 10.2174/157340808785909376
Published on: 01 March, 2012

The NPC1L1 Inhibitor Ezetimibe in the Treatment of the Dyslipidemia in Patients Affected by the Metabolic Syndrome: Evidences and Perspectives

Volume:4   Issue: 3
Pp: 109-120
Giovanni Anfossi, Chiara Frascaroli, Katia Bonomo, Massimo Chirio, Chiara Giordanino and Mariella Trovati
DOI: 10.2174/157340808785909411
Published on: 01 March, 2012

Recent Findings on the Multifaceted Functionality of Enzyme Inhibition by Natural Compounds: A Review

Volume:4   Issue: 3
Pp: 121-152
John Paul Delano-Frier, Jose Luis Castro-Guillen and Alejandro Blanco-Labra
DOI: 10.2174/157340808785909385
Published on: 01 March, 2012

Aurora B Kinase and Passenger Proteins as Targets for Cancer Therapy

Volume:4   Issue: 3
Pp: 153-159
Thi My Nhung Hoang, Marlene Delacour-Larose and Annie Molla
DOI: 10.2174/157340808785909402
Published on: 01 March, 2012